CHRS
Coherus Onco (CHRS)
NASDAQ
$1.36+$0.03 (+2.26%)
Price as of Sep 11, 2026 7:30 PM EDT
  • $205.5M
    Market Cap
  • 3.10%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

N/A
Valuation
CHRS
vs History
vs S&P 500
Profitability
1
Growth
0
Low Earnings Volatility
5

Momentum Score

Score: 45
Valuation
CHRS
vs History
vs S&P 500
3-Month Momentum
-17.61%
12-Month Momentum
-12.03%
3-Month Risk Adjusted Momentum
-71.03%
12-Month Risk Adjusted Momentum
-15.53%

True Yield

N/A
Valuation
CHRS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
-0.05%

Financial Health Score

N/A
Valuation
CHRS
vs History
vs S&P 500
Ohlson's O-Score
8